|
| Baseline characteristics | Nondied | Died | |
|
| Age (years) | 56.19 ± 11.27 | 56.99 ± 12.43 | 0.502 |
| Sex (number of cases (%)) | | | 0.157 |
| Female/male | 61 (18.3)/272 (81.7) | 17 (12.9)/115 (87.1) | |
| Drinking (number of cases (%)) | | / | 0.571 |
| No/yes | 270 (81.1)/63 (18.9) | 110 (83.3)/22 (16.7) | |
| Smoking (number of cases (%)) | | | 0.704 |
| No/yes | 238 (71.5)/95 (28.5) | 92 (69.7)/40 (30.3) | |
| NLR | 1.9 (1.5, 2.6) | 2.4 (1.8.3.5) | 0.001 |
| PLR | 90.5 (68.6, 124.3) | 104.5 (78.0, 146.5) | 0.002 |
| AGR | 1.43 ± 0.27 | 1.36 ± 0.26 | 0.008 |
| Intraoperative bleeding (ml) | 200 (100, 300) | 225 (100.425) | 0.001 |
| Tumor size (number of cases (%)) | | | 0.002 |
| ≤5/>5 cm | 172 (51.6)/161 (48.4) | 47 (35.6)/85 (64.4) | |
| Cirrhosis (number of cases (%)) | | | 0.927 |
| No/yes | 77 (23.1)/256 (76.9) | 30 (22.7)/102 (77.8) | |
| MVI (number of cases (%)) | | | 0.011 |
| None/yes | 228 (68.5)/105 (31.5) | 74 (56.1)/58 (43.9) | |
| Number of tumors (number of cases (%)) | | | 0.158 |
| 1/≥2 | 296 (88.9)/37 (11.1) | 111 (84.1)/21 (15.9) | |
| Intact capsule (number of cases (%)) | | | 0.993 |
| No/yes | 68 (20.4)/265 (79.6) | 27 (20.5)/105 (79.5) | |
| Anatomical resection (number of cases (%)) | | | 0.802 |
| No/yes | 246 (73.9)/87 (26.1) | 99 (75.0)/33 (25.0) | |
| AFP (number of cases (%)) | | | 0.151 |
| <400/≥400 ng/ml | 230 (69.1)/103 (30.9) | 82 (62.1)/50 (37.9) | |
| Edmondson (number of cases (%)) | | | 0.002 |
| I and II/III and IV | 253 (76.0)/80 (24.0) | 81 (61.4)/51 (38.6) | |
| Anti-HBc (number of cases (%)) | | | 0.881 |
| Positive/negative | 322 (96.7)/11 (3.3) | 128 (97.0)/4 (3.0) | |
| HBsAg (number of cases (%)) | | | 0.657 |
| Positive/negative | 283 (85.0)/50 (15.0) | 110 (83.3)/22 (16.7) | |
| HBV-DNA (number of cases (%)) | | | 0.057 |
| <1000/≥1000 copies/ml | 135 (40.5)/198 (59.5) | 41 (31.1)/91 (68.9) | |
| ALT (number of cases (%)) | | | 0.369 |
| ≤50/>50 U/L | 253 (76.0)/80 (24.0) | 95 (72.0)/37 (28.0) | |
| ALB (number of cases (%)) | | | 0.184 |
| ≥35/<35 g/L | 310 (93.1)/23 (6.9) | 118 (89.4)/14 (10.6) | |
| TB (number of cases (%)) | | | 0.030 |
| ≤20.5/>20.5 μmol/L | 268 (80.5)/65 (19.5) | 94 (71.2)/38 (28.8) | |
| PT (number of cases (%)) | | | 0.113 |
| ≤14/>14 s | 312 (93.7)/21 (6.3) | 118 (89.4)/14 (10.6) | |
| Ascites (number of cases (%)) | | | 0.235 |
| No/yes | 287 (86.2)/46 (13.8) | 108 (81.8)/24 (18.2) | |
| Perioperative blood transfusion (number of cases (%)) | | | 0.054 |
| None/yes | 278 (83.5)/55 (16.5) | 100 (75.8)/32 (24.2) | |
| Laparoscope (number of cases (%)) | | | 0.164 |
| Yes/no | 40 (12.0)/293 (88.0) | 10 (7.6)/122 (92.4) | |
| Operation duration (number of cases (%)) | | | 0.798 |
| >120/≤120 min | 186 (55.9)/147 (44.1) | 72 (54.6)/60 (45.4) | |
| Child–Pugh (number of cases (%)) | | | 0.064 |
| A/B | 333 (100.0)/0 (0.0) | 130 (98.9)/2 (1.5) | |
| CNLC (number of cases (%)) | | | 0.054 |
| Ia/Ib/IIa/IIb | 187 (56.2)/112 (33.6)/30 (9.0)/4 (1.2) | 53 (40.2)/60 (45.4)/15 (11.4)/4 (3.0) | |
| BCLC (number of cases (%)) | | | 0.015 |
| 0/A/B | 27 (8.1)/278 (83.5)/28 (8.4) | 3 (2.3)/110 (83.3)/19 (14.4) | |
|
